Form 4: Hims & Hers Health Director David B. Wells Reports Stock Transactions
SEC Form 4 Filing
Director David B. Wells reports the vesting and conversion of restricted stock units into Class A Common Stock.
Summary
- On June 14, 2024, David B. Wells, a director of Hims & Hers Health, Inc., reported transactions involving restricted stock units (RSUs).
- Wells converted 10,046 RSUs into Class A Common Stock.
- Following the reported transactions, Wells beneficially owns 185,992 shares of Class A Common Stock.
- The RSUs vest over a 4-year period, with 25% vesting after the first year (starting December 15, 2020) and the remaining 75% vesting in equal quarterly installments.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing related to stock transactions, so the sentiment is neutral.
Industry Context
Form 4 filings are standard disclosures required by the SEC for insiders (directors, officers, and 10% owners) to report transactions in their company's stock, providing transparency to the market.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in the director's holdings.
Key Dates
| Date | Description |
|---|---|
| December 15, 2020 | Start date for RSU vesting schedule. |
| June 14, 2024 | Date of the reported stock transactions. |
| June 18, 2024 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.